生命科学资讯

Novartis cuts hundreds of jobs; Novo’s dual-acting diabetes drug heading to Phase 3

Otsuka gains approval for first-of-its-kind treatment against rare kidney disease

CMS sets 2027 Medicare prices for Wegovy, Trelegy and 13 other drugs

Novartis wins approval to use SMA gene therapy in older patients

Gilead scoops up a preclinical cancer program

How do Big Pharma employees rate their CEOs?

Kelun, Merck tout ADC as potential first-line treatment in lung cancer

Bayer’s experimental blood-thinner notches trial win in stroke prevention

Novo Nordisk’s GLP-1 misses goal in closely watched Alzheimer’s studies

FDA probes effects of Takeda rare disease drug after patient death

Biogen strikes deal with Versant-backed biotech to expand immune portfolio

APOE4 and CRISPR are reframing Alzheimer’s Risk

Eli Lilly becomes first drugmaker to hit $1 trillion in market value

FDA tests new program to speed drugmaker talks; Bezos-linked AI startup raises $106M

GSK, Anaptysbio sue each other over Jemperli revenue

A brain biotech’s top drug fails against MS

Moderna secures $1.5B lifeline as it looks to break even in 2028

Roche pill notches win in early breast cancer - BioPharma Dive

Roche’s MS tablet scores in late-stage studies - BioPharma Dive

Roche taps an AI specialist to craft new brain drugs - BioPharma Dive